Streetbeat News

Stock Prices

AEMD

CMRX

GOVX

INO

MRNA

SIGA

TNXP

WHO Director-General Tedros Adhanom Ghebreyesus has declared Mpox a Public Health Emergency of International Concern. This announcement could impact companies involved in vaccine and treatment development for Mpox.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:27 pm

BABA

BIDU

BILI

EDU

HCM

JD

LI

NIO

PDD

TAL

TCOM

ZTO

Shares of US-listed Chinese stocks are trading lower ahead of upcoming economic data.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:22 pm

MDLZ

Members of Teamsters Local 104 working at Mondelēz have unanimously authorized a strike, according to the Teamsters union.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:11 pm

CLOV

Clover Health Investments shares are trading higher following the purchase of shares by director Vivek Garipalli.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:10 pm

YMAB

Y-mAbs Therapeutics shares are trading, potentially rebounding after a decline earlier in the week due to weak earnings and guidance.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:06 pm

GILD

The FDA has approved Gilead Sciences' new drug, Livdelzi, for the treatment of Primary Biliary Cholangitis, according to Reuters citing the company's website.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:03 pm

RIOT

Riot Platforms, Inc. (NASDAQ:RIOT) announced the acquisition of one million common shares of Bitfarms, increasing its ownership to 18.90%. Additionally, Riot reported a significant increase in Bitcoin production and hash rate for July 2024, and announced the acquisition of Block Mining, which will boost its self-mining capacity. Despite these positive developments, Riot's stock is down 2.68% to $7.63.

Portfolio Pulse from Dylan Berman

August 14, 2024 | 5:03 pm

LYFT

Over the past three months, 28 analysts have provided ratings for Lyft (NASDAQ:LYFT), with a mix of bullish, somewhat bullish, and indifferent sentiments. The average 12-month price target has decreased by 12.61% to $16.43. Recent analyst actions predominantly involve lowering price targets and ratings, reflecting cautious sentiment towards Lyft's stock. Despite this, Lyft has shown positive financial performance with significant revenue growth, strong net margin, ROE, and ROA, and balanced debt management.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 5:01 pm

TJX

12 analysts have provided ratings for TJX Companies (NYSE:TJX) over the past quarter, with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased by 4.15% to $119.25. Analysts have raised their price targets, reflecting positive market conditions and company performance.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 5:01 pm

AMAT

IYJ

JEPQ

NU

The CNBC Halftime Report highlighted final trades including Applied Materials, Nu Holdings, iShares U.S. Industrials ETF, and JPMorgan Nasdaq Equity Premium Income ETF.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:01 pm